Feng Yajuan, Mao Zhi-Gang, Wang Xin, Du Qiu, Jian Mengyao, Zhu Dimin, Xiao Zheng, Wang Hai-Jun, Zhu Yong-Hong
Department of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
Horm Metab Res. 2018 Mar;50(3):179-192. doi: 10.1055/s-0043-123763. Epub 2018 Jan 19.
Pituitary adenomas account for the top three primary intracranial tumors in terms of total incidence rates. The clinical symptoms presented by the disease are often characterized by a series of systemic endocrine disorders, severe occupational lesions, and even some malignant features, and therefore early diagnosis and predicting recurrence would be instructive for clinical treatment of pituitary adenomas. An increasing number of specific microRNA (miRNA) expression signatures have been identified in pituitary, and miRNAs are related with the pituitary tumorigenesis, dysfunction, neurodegeneration, and metastatic non-functioning pituitary carcinoma. Here, this paper reviews the effects of aberrant miRNA expression in human pituitary adenomas and summarizes some corresponding target genes and biological significance over the last 7 years (2010-2017).
垂体腺瘤在总发病率方面位列原发性颅内肿瘤的前三位。该疾病呈现的临床症状通常表现为一系列全身性内分泌紊乱、严重的职业性损害,甚至具有一些恶性特征,因此早期诊断和预测复发对垂体腺瘤的临床治疗具有指导意义。在垂体中已鉴定出越来越多的特异性微小RNA(miRNA)表达特征,并且miRNA与垂体肿瘤发生、功能障碍、神经退行性变以及转移性无功能垂体癌相关。在此,本文回顾了过去7年(2010 - 2017年)异常miRNA表达在人类垂体腺瘤中的作用,并总结了一些相应的靶基因及生物学意义。